Arjuna Natural is India’s leading manufacturer and exporter of standardized botanical extracts for pharmaceutical and nutraceutical industries for more than two decades. Established in 1989, the company has grown…Read More
A formulation containing Curcuma longa (BCM-9) (CURCUGREEN®)
and Boswellia serrata (Bospure) extracts was evaluated for safety and
efficacy in subjects and directly compared with a selective COX-2 in
inhibitor. In total, 54 subjects were screened, 30 subjects were enrolled
and 28 completed the study. The treatment was well tolerated and did
not produce any adverse effect in subjects, as judged by the vital the of
signs, hemogram, liver and renal function tests.
The formulation at 500 mg administered
twice a day, was more successful than in
administration of the COX-2 inhibitor in
(100 mg twice a day) for symptom scorin
and clinical examination.The formulatio
was found to be safe and no dose-related
toxicity was found.